Victor V. Zhirnov

Victor V. Zhirnov

Auto-generated profile, based on publicly available information

Victor V. Zhirnov

Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in ChemMedChem
Verified
Journal Article
Open access
MBMykhailo Brusnakov
Mykhailo Brusnakov
OGOlexandr Golovchenko
Olexandr Golovchenko
YVYevheniia Velihina
Yevheniia Velihina
OLOleksandr Liavynets
Oleksandr Liavynets
VZVictor Zhirnov
Victor Zhirnov
VBVolodymyr S. Brovarets
Volodymyr S. Brovarets
A novel series of 1,3‐oxazol‐4‐yltriphenylphosphonium salts has been synthesized and functionalized. Oxazole derivatives were subjected to NCI in vitro assessment. Seven most active derivatives have been selected for five‐dose assay. Among them, compounds 9 ([2‐(4‐methylphenyl)‐5‐[(4‐methylphenyl)sulfanyl]‐1,3‐oxazol‐4‐yl]triphenylphosphonium perchlorate), 1 ([5‐(4‐methylphenyl)amino]‐2‐phenyl‐1,3‐oxazol‐4‐yl]triphenylphosphonium perchlorate) and 4 ([5‐phenyl‐2‐[(4‐methylphenyl)amino]‐1,3‐oxazol‐4‐yl]triphenylphosphonium perchlorate) were the most active against all tested cancer subpanels. Statistical analysis of the total panel data showed average values of parameters of anticancer activity in the range of 0.3–1.1 μM (GI50), 1.2–2.5 μM (TGI) and 5–6 μM (LC50). It was found that the presence of phenyl or 4‐methylphenyl groups at C(2) and C(5) in the oxazole ring is of critical importance for the manifestation of the anticancer activity. Matrix COMPARE analysis using LC50 vector showed a high positive correlation of compound 9 with standard anticancer agents that can directly disrupt mitochondrial function, causing programmed death of cancer cells. The obtained results indicate the anticancer activity of 1,3‐oxazol‐4‐ylphosphonium salts, which could be useful for developing new anticancer drugs. The most active of them can be recommended for further in‐depth studies and synthesis of new derivatives with antitumor activity on their basis.


24 May 2023 in ChemMedChem
Verified
Journal Article
Open access
VZVladimir Zyabrev
Vladimir Zyabrev
SPStepan Pilyo
Stepan Pilyo
BDBohdan Demydchuk
Bohdan Demydchuk
MKMaryna Kachaeva
Maryna Kachaeva
ISIvan V. Semenyuta
Ivan V. Semenyuta
VBVolodymyr S. Brovarets
Volodymyr S. Brovarets
A novel series of 5‐sulfinyl(sulfonyl)‐4‐arylsulfonyl‐substituted 1,3‐oxazoles has been synthesized, characterized and subjected to NCI in vitro assessment. Cancer cell lines of all subpanels were most sensitive to 2‐{[4‐[(4‐fluorophenyl)sulfonyl]‐2‐(2‐furyl)‐1,3‐oxazol‐5‐yl]sulfinyl}acetamide (3 l). Its antiproliferative and cytotoxic activity averaged over each subpanel was manifested in a very narrow range of concentrations (GI50: 1.64–1.86 μM, TGI: 3.16–3.81 μM and LC50: 5.53–7.27 μM), i. e. practically did not depend on the origin of the cancer cell line. The COMPARE matrix using TGI vector showed a high positive correlation of 3 l (r=0.88) with the intercalating agent aclarubicin, which inhibits topoisomerases. The absence in the database of standard agents that have a high correlation with the cytotoxicity of this compound suggests that it may have a unique mechanism of action. According to the results of the docking analysis, the most promising anticancer target for compound 3 l is DNA topoisomerase IIβ. The obtained results indicate the anticancer activity of 5‐sulfinyl(sulfonyl)‐4‐arylsulfonyl‐substituted 1,3‐oxazoles, which may be useful for the development of new anticancer drugs. 2‐{[4‐[(4‐Fluorophenyl)sulfonyl]‐2‐(2‐furyl)‐1,3‐oxazol‐5‐yl]sulfinyl}acetamide (3 l), as the most active, can be recommended for further in‐depth studies.

15 May 2010 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
PDF file
VZVictor V. Zhirnov
Victor V. Zhirnov
SKSvetlana V. Khyzhnyak
Svetlana V. Khyzhnyak
VVVladimir M. Voitsitskiy
Vladimir M. Voitsitskiy
To determine the effects of ultra-low dose beta-radiation (ULDBR) on the physical properties of human erythrocyte membranes. To study the structural changes induced by beta-radiation in erythrocyte ghosts, the interactions of fluorescent probes (1-anilino-8-naphthalene sulfonate, pyrene) with the erythrocyte membranes were investigated. The fluorescent responses to the ULDBR were registered after the addition of (14)C-leucine (37-3700 kBq(l(-1)) in the cellular suspension. The ULDBR induced essential rearrangements of the membrane structure that appear in alterations of membrane spatial organisation, conformation of membrane proteins (structural flexibility, folding-unfolding), modification of surface and deep zones of membranes, lipid-protein interactions, and fluidity of annular lipids. These findings are evidence that, as previously discovered by us, the reversible effect of ULDBR on the zeta potential of human erythrocytes and the functional state of the membrane signal systems is most likely realised through local structural and dynamic rearrangements of macromolecules in cellular membranes.

17 June 2014 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
VZVictor V. Zhirnov
Victor V. Zhirnov
IIIgor N. Iakovenko
Igor N. Iakovenko
Purpose: To investigate the effects of the imposed low dose rate ionizing field on membrane stability of human erythrocytes under modulation of transmembrane exchange of Ca2+. Materials and methods: Osmotic resistance of human erythrocytes was determined by a measure of haemoglobin released from erythrocytes when placed in a medium containing serial dilutions of Krebs isotonic buffer. The zeta potential as indicator of surface membrane potential was calculated from value of the cellular electrophoretic mobility. The irradiation of erythrocyte suspensions carried out by applying suitable aliquots of Sr-90 in incubation media. Results: Irradiation of human erythrocytes by Sr-90 (1.5-15.0 mu Gy.h(-1)) induced a reversible increase of hyposmotic hemolysis and negative charge value on the outer membrane surface as well as changed responses these parameters to modification of Ca2+ fluxes with calcimycin and nitrendipine. Conclusions: Findings indicate that the low dose rate radionuclides (Sr-90) field modifies both Ca2+-mediated, and Ca2+ independent cellular signalling regulating mechanical stability of erythrocyte membrane. A direction of that modification presumably depends on the initial structure of membranes, and it is determined by the quality and quantitative parameters of changes in membrane structure caused by concrete operable factors.

1 August 2025 in Current Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
ISIvan V. Semenyuta
Ivan V. Semenyuta
OLOleksandr Los
Oleksandr Los
VSVitalii Sinenko
Vitalii Sinenko
VZVictor Zhirnov
Victor Zhirnov
LPLyudmyla Potikha
Lyudmyla Potikha
VBVolodymyr S. Brovarets
Volodymyr S. Brovarets
Background: Indole is considered the most promising scaffold for anticancer drug design due to its high bioavailability, unique chemical properties, and broad spectrum of pharmacological action. Objective: Twelve novel thiazole-containing the 5-fluoro-1,3-dihydro-2H-indol-2-one derivatives as sunitinib analogs were designed and synthesized, and their anticancer activity was evaluated against the NCI-60 cancer cell lines. Methods: The thiazole-contained 5-fluoro-1,3-dihydro-2H-indol-2-one derivatives were synthesized using Knoevenagel condensation of 1,3-thiazole-5-carboxylic acid 1. Their anticancer activities were evaluated by NCI-60 one-dose screen assay. The molecular docking studies were performed using AutoDock tools and the AutoDock Vina programs. The ADMETlab 2.0 web server predicted the physicochemical properties of compounds. Results: Among the synthesized new 5-fluoro-2-oxindole derivatives, compound 3g demonstrated high antitumor activity (GI>70%) against eight types of cancer: leukemia, breast cancer, ovarian cancer, lung cancer, melanoma, CNS cancer, renal cancer, and colon cancer. The most activity was observed against breast cancer (T-47D, GI=96.17%), lung cancer (HOP-92, GI=95.95%), ovarian cancer (NCI/ADR-RES, GI=95.13%), and CNS cancer (SNB-75, GI=89.91%). The molecular docking results of compound 3g demonstrated the possibility of inhibiting VEGF2 receptors as his potential anticancer mechanism. The physicochemical properties predicted for compounds 3f and 3g showed positive results. Conclusion: Compound 3g demonstrated high in vitro NCI-60 anticancer activity against nine cancer types and showed cell growth inhibition against leukemia, CNS, and breast cancer at 6 - 31% higher than Sunitinib, and may represent the basis for further modification of the thiazole-containing analogs of the anticancer drug Sunitinib. Conclusion: Compound 3g demonstrated high in vitro NCI-60 anticancer activity against nine cancer types and showed cell growth inhibition against leukemia, CNS, and breast cancer at 6 - 31% higher than Sunitinib, and may represent the basis for further modification of the thiazole-containing analogs of the anticancer drug Sunitinib.